tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CRVS Stock Latest News

3 ‘Strong Buy’ Biotech Stocks to Buy Now, 1/29/2026, According to Top Analysts
Market News3 ‘Strong Buy’ Biotech Stocks to Buy Now, 1/29/2026, According to Top Analysts
15d ago
CRVS
NRIX
Corvus Pharmaceuticals price target raised to $30 from $20 at Mizuho
PremiumThe Fly
Corvus Pharmaceuticals price target raised to $30 from $20 at Mizuho
15d ago
CRVS
Mizuho biotech analysts hold an analyst/industry conference call
PremiumThe Fly
Mizuho biotech analysts hold an analyst/industry conference call
20d ago
APGE
CRVS
Corvus Pharmaceuticals Announces Major Underwritten Public Stock Offering
PremiumCompany Announcements
Corvus Pharmaceuticals Announces Major Underwritten Public Stock Offering
21d ago
8K
CRVS
Corvus Pharmaceuticals price target raised to $42 from $13 at Jefferies
PremiumThe Fly
Corvus Pharmaceuticals price target raised to $42 from $13 at Jefferies
21d ago
CRVS
Corvus Pharmaceuticals 7.9M share Secondary priced at $21.15
PremiumThe FlyCorvus Pharmaceuticals 7.9M share Secondary priced at $21.15
22d ago
CRVS
Corvus Pharmaceuticals price target raised to $32 from $15 at Oppenheimer
Premium
The Fly
Corvus Pharmaceuticals price target raised to $32 from $15 at Oppenheimer
23d ago
CRVS
Closing Bell Movers: Netflix down 5% after soft guidance
Premium
The Fly
Closing Bell Movers: Netflix down 5% after soft guidance
23d ago
HWC
OZK
Corvus Pharmaceuticals Suspends At-The-Market Equity Program
PremiumCompany Announcements
Corvus Pharmaceuticals Suspends At-The-Market Equity Program
23d ago
8K
CRVS
Corvus Pharmaceuticals announces $150M common stock offering
PremiumThe Fly
Corvus Pharmaceuticals announces $150M common stock offering
23d ago
CRVS
Corvus Pharmaceuticals price target raised to $28 from $16 at Barclays
PremiumThe Fly
Corvus Pharmaceuticals price target raised to $28 from $16 at Barclays
23d ago
CRVS
Corvus Pharmaceuticals price target raised to $20 from $13 at Mizuho
PremiumThe Fly
Corvus Pharmaceuticals price target raised to $20 from $13 at Mizuho
23d ago
CRVS
Midday Fly By: Netflix and Warner amend deal, GSK to acquire Rapt
PremiumThe FlyMidday Fly By: Netflix and Warner amend deal, GSK to acquire Rapt
23d ago
MU
PM
Corvus Pharmaceuticals: Undervalued Buy on Soquelitinib’s Promising Data, Expanding Immunology Pipeline, and Multiple Upcoming Catalysts
Premium
Ratings
Corvus Pharmaceuticals: Undervalued Buy on Soquelitinib’s Promising Data, Expanding Immunology Pipeline, and Multiple Upcoming Catalysts
23d ago
CRVS
Corvus Pharmaceuticals price target raised to $27 from $11 at H.C. Wainwright
Premium
The Fly
Corvus Pharmaceuticals price target raised to $27 from $11 at H.C. Wainwright
23d ago
CRVS
Corvus Pharmaceuticals reports positive Phase 1 soquelitinib results
PremiumCompany Announcements
Corvus Pharmaceuticals reports positive Phase 1 soquelitinib results
24d ago
8K
CRVS
Corvus announces results from cohort 4 of Phase 1 trial of soquelitinib
PremiumThe Fly
Corvus announces results from cohort 4 of Phase 1 trial of soquelitinib
24d ago
CRVS
Corvus Pharmaceuticals confirms plans to announce results of Soquelitinib trial
PremiumThe Fly
Corvus Pharmaceuticals confirms plans to announce results of Soquelitinib trial
1M ago
CRVS
Corvus presents final data from soquelitinib Phase 1/1b T cell lymphoma trial
PremiumThe Fly
Corvus presents final data from soquelitinib Phase 1/1b T cell lymphoma trial
2M ago
CRVS
Corvus Pharmaceuticals management to meet with Cantor
PremiumThe FlyCorvus Pharmaceuticals management to meet with Cantor
2M ago
CRVS
Corvus Pharmaceuticals Reports Positive Q3 Earnings Call
Premium
Company Announcements
Corvus Pharmaceuticals Reports Positive Q3 Earnings Call
3M ago
CRVS
Corvus Pharmaceuticals Advances Clinical Trials for Soquelitinib
Premium
Company Announcements
Corvus Pharmaceuticals Advances Clinical Trials for Soquelitinib
3M ago
CRVS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >